Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06545409

Serratus Posterior Superior Intercostal Plane Block in Robotic-Assisted Thymectomy

Led by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Updated on 2025-03-25

28

Participants Needed

1

Research Sites

80 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study aims to assess the effectiveness of the Serratus Posterior Superior Intercostal Plane Block (SPSIP Block) for postoperative pain control, reducing opioid analgesic consumption, minimizing postoperative respiratory complications, and enhancing patient satisfaction (measured using the QoR-15 index) in patients undergoing robotic thymectomy, compared to patients who do not receive the block.

CONDITIONS

Official Title

Serratus Posterior Superior Intercostal Plane Block in Robotic-Assisted Thymectomy

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients affected by thymoma, thymic hyperplasia, or thymic pathologies such as cysts or teratomas
  • Patients who have given informed consent to participate in the study
Not Eligible

You will not qualify if you...

  • Patients who do not provide informed consent
  • Patients with myasthenia gravis
  • Patients with severe obesity (BMI > 35)
  • Patients with a history of obstructive sleep apnea syndrome (OSAS) with or without CPAP
  • Patients classified as ASA class greater than 3
  • Patients unable to understand the Numeric Pain Rating Scale or PCA device
  • Patients allergic to analgesic or anesthetic drugs
  • Patients on anticoagulant therapy
  • Patients with a history of chronic pain
  • Patients with infection at the site of the SPSIP Block
  • Patients with previous thoracic surgery or trauma with rib fractures on the surgery side
  • Patients with chest deformities or neuromuscular diseases affecting normal breathing
  • Patients whose surgery is converted to sternotomy thymectomy during the procedure

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Fondazione Policlinico A.Gemelli IRCCs

Rome, Italy, 00135

Actively Recruiting

Loading map...

Research Team

G

Giovanni Punzo, MD

CONTACT

D

Dania Nachira, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here